Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
International Immunopharmacology (2020) - Comments
doi: 10.1016/j.intimp.2020.107205  issn: 1567-5769 

Payam Tabarsi, Saghar Barati, Hamidreza Jamaati, Sara Haseli, Majid Marjani, Afshin Moniri, Zahra Abtahian, Alireza Dastan, Sahar Yousefian, Raha Eskandari, Ali Saffaei, Fatemeh Monjazebi, Abdolbaset Vahedi, Farzaneh Dastan